PeerVoice
PeerVoice Oncology & Haematology Audio
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Oncology & Haematology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes? 17.11.2022 37:57
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat 01.11.2022 21:53
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022 27.10.2022 23:25
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals 19.10.2022 18:08
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC 04.10.2022 1:20:14
Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice 03.10.2022 24:30
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC 29.09.2022 27:59
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit 29.09.2022 18:54
Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC 20.09.2022 24:14
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care 07.09.2022 55:11
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions 07.09.2022 20:08
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
Question Time: Applying New Therapies for the Management of mTNBC 29.08.2022 38:18
Question Time: Applying New Therapies for the Management of mTNBC
New Biomarkers, New Targets in Advanced NSCLC 17.08.2022 20:20
New Biomarkers, New Targets in Advanced NSCLC
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias 01.08.2022 18:31
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
IAP Antagonists in Oncology: What Do We Know? 25.07.2022 23:36
IAP Antagonists in Oncology: What Do We Know?
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC 11.07.2022 37:39
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022 30.06.2022 19:16
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors 26.05.2022 21:38
Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID 18.05.2022 21:28
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B 16.05.2022 18:44
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
Personalising Management of Advanced RCC: How I Treat 16.05.2022 9:19
Personalising Management of Advanced RCC: How I Treat
Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World 05.05.2022 11:42
Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course 26.04.2022 38:34
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course
Complex Cases of Comorbidities in Patients With HCV 21.04.2022 20:20
Complex Cases of Comorbidities in Patients With HCV
"Defining the Diagnosis and Management of Pyruvate Kinase Deficiency" 20.04.2022 21:02
"Defining the Diagnosis and Management of Pyruvate Kinase Deficiency"
Similar podcasts
Listen to the PeerVoice Oncology & Haematology Audio podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
